Why the study?
Does doxorubicin treatment alter protein expression profiles in H9c2 cardiomyocytes?
Does doxorubicin treatment alter protein expression profiles in H9c2 cardiomyocytes?
Proteomic profiling of doxorubicin-treated cardiomyocytes identified 22 differentially expressed proteins, highlighting cathepsin B and NF-κB as potential mediators of doxorubicin-induced cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Doxorubicin alters cardiomyocyte protein expression; hypothesis-generating for cathepsin B and NF-κB roles pending in vivo validation.
A 2012 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: